Comparing Cisplatin Dosing Schedules in Concurrent Chemoradiotherapy for Locally Advanced Head-and-Neck Cancer: A Comprehensive Review of Weekly Versus 3-Weekly Regimens
Objective: There are approximately 900,000 new cases of head-and-neck cancer (HNC) annually, with a significant proportion presenting as locally advanced head-and-neck cancer (LA-HNC). Cisplatin-based concurrent chemoradiotherapy (CCRT) has become widely accepted, particularly for patients deemed in...
Saved in:
Main Authors: | Oscar Chi-Yu Yang, Nai-Wen Su, Yi-Shing Leu, Yi-Fang Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Cancer Research and Practice |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-24-00010 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renal protective effect of a hydration supplemented with magnesium in patients receiving cisplatin for head and neck cancer
by: Takahiro Kimura, et al.
Published: (2018-02-01) -
Effects of Repeated Cisplatin and Monosodium Glutamate on Visceral Sensitivity in Rats
by: Yolanda López-Tofiño, et al.
Published: (2024-12-01) -
Oncological outcomes in non-seminomatous testicular tumors and residual mass after cisplatin-based chemotherapy
by: María A. Ocampo-Gómez, et al.
Published: (2024-04-01) -
Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy
by: Chih-Chung Cheng, et al.
Published: (2024-12-01) -
COMBINED TREATMENT OF LOCALLY-ADVANCED BLADDER CANCER
by: I. V. Chernyshev, et al.
Published: (2016-01-01)